sub banner

About LambdaVision

About | Management Team | Board of Directors

LambdaVision is designing and developing an innovative, protein-based artificial retina that utilizes a light-activated protein, bacteriorhodopsin, to restore functional sight to those who would otherwise be blind due to retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). No cure exists for these diseases, and currently available treatments only slow their progression. There is a significant unmet need for the development of a treatment that restores meaningful vision to those affected. Through the development of an artificial retina, LambdaVision hopes to one day help patients regain vision so that they can complete everyday tasks with independence.

LambdaVision was founded by a group of researchers led by Dr. Robert R. Birge, a distinguished professor of chemistry at UConn and a pioneer in the field of light-sensitive proteins.


Contact

400 Farmington Avenue
Farmington, CT 06032
Click Here for Map
info@lambdavision.com

sub banner

Home | About | Indications | Product | Newsroom | Resources
 © 2020 LambdaVision, Inc. All Rights Reserved. Website by J. A. Greco.